hotspot -WSS

hotspot

author：focus 2025-10-02 18:50:18 - browse：3321

Adobe

Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals, and other health care facilities as part of its response to the February 21 Change Healthcare cyberattack.

The payments are meant to fund providers that aren’t able to submit claims to Medicare because of the disruption to Change’s data network and have exhausted all other potential avenues of funding. Medicare will advance up to 30 days of payment, based on the average monthly amount a provider received from Medicare from August 1 to October 31, 2023. The providers are expected to repay the money 90 days after receiving the payment, with interest beginning to accrue 30 days after that.

“We welcome today’s announcement and will continue to work with policymakers as the impacts from the cyberattack persist,” the American Hospital Association said in a statement after the announcement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

WSS

Oprah kicked off a national conversation on obesity. Let's have it

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Why the world’s most expensive drug might be worth the price

FDA has safety concerns on CRISPR

Supreme Court mifepristone arguments center on docs' right to sue

entertainment

hotspot

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Alkermes shareholders re

Meta's Zuckerberg and Chan on track to put $50 billion into science

At least 13 dead in Texas as scorching temps continue

Hospitals warn Medicare's drug payment fix is ‘unlawful’

United colonoscopy coverage change 'may cost lives,' doctors say

Covid vaccine financial winners and losers, from Pfizer to Novavax

Virginia high school admissions case could be legal follow

Donor acceptance rates hint at racial, gender bias in heart transplants: study

focus

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Testing for cancer recurrence creates a new limbo for patients

Readout LOUD podcast: mifepristone case, GLP

There's no autism epidemic. It's an autism diagnosis epidemic

Supreme Court mifepristone arguments center on docs' right to sue

leisure time

explore

leisure time

knowledge